TITLE

Comparative evaluation of various solubility enhancement strategies for furosemide

AUTHOR(S)
Murtaza, Ghulam; Khan, Shujaat Ali; Najam-ul-Haq, Muhammad; Hussain, Izhar
PUB. DATE
July 2014
SOURCE
Pakistan Journal of Pharmaceutical Sciences;Jul2014, Vol. 27 Issue 4, p963
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Drugs with good solubility exhibit good oral absorption, and subsequently good bioavailability. Thus, most exigent phase of drug development practice particularly for oral dosage forms is the enhancement of drug solubility. This review describes various traditional and novel methodologies proposed for the solubility enhancement of furosemide. For furosemide, solubility and permeability are crucial rate limiting factors to achieve its desired level in systemic circulation for pharmacological response. Thus, problematic solubility of furosemide is one of the main challenges for dosage form developing researchers. Various procedures, illustrated in this review, have been successfully employed to improve the furosemide solubility; however successful improvement essentially depends on the assortment of technique. It is concluded from the results that dissolution rate of drug increases by increasing the quantity of solubility enhancer. Dissolution rate also depends upon the type of enhancer and dissolution medium. In order to achieve relatively enhanced percentage drug release after 30 min (DP30), complexation by solvent evaporation using β-cyclodextrin is the best method. Solid dispersion is found the best if polyethylene glycol is used as enhancer along with microcrystalline cellulose as hydrophilic adsorbent. All the approaches narrated in this article possess good perceptions for additional research i.e. in-vivo studies should be carried out focusing on delivery system development.
ACCESSION #
96960076

 

Related Articles

  • Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems. Shweta Gupta; Rajesh Kesarla; Abdelwahab Omri // ISRN Pharmaceutics;2013, p1 

    Poorly water-soluble drug candidates are becoming more prevalent. It has been estimated that approximately 60-70% of the drug molecules are insufficiently soluble in aqueous media and/or have very low permeability to allow for their adequate and reproducible absorption from the gastrointestinal...

  • Recent Advances in Lipid-Based Formulation Technology. Porter, Christopher J. H.; Williams, Hywel D.; Trevaskis, Natalie L. // Pharmaceutical Research;Dec2013, Vol. 30 Issue 12, p2971 

    No abstract available.

  • A review on bio-availability enhancement techniques of poorly soluble drug. Khan, Anwar; Malviya, Rishabha; Sharma, Pramod K. // International Journal of Pharmacy;Jul2014, Vol. 4 Issue 3, p260 

    Solubility is the process of dissolution of solid in liquid phase to give a homogenous system and is one of the important parameter to achieve desired concentration of drug in systemic circulation for pharmacological response. Dissolution rate of poorly water-soluble drugs is rate limiting step...

  • SMEDDS incorporated polymer matrix: a floating dosage form solution for drugs with poor gastric solubility. Patel, Ashok R.; Vavia, Pradeep R. // Pharmaceutical Technology Europe;Mar2010, Vol. 22 Issue 3, p36 

    The article discusses a study that seeks to provide solutions in achieving gastro-retention and aqueous solubility of drugs. Furosemide (FUR) was used as the subject of the research due to its limited solubility and bioavailability. FUR was enhanced through the application of self...

  • Population pharmacokinetics of afatinib, an irreversible ErbB family blocker, in patients with various solid tumors. Freiwald, Matthias; Schmid, Ulrike; Fleury, Angele; Wind, Sven; Stopfer, Peter; Staab, Alexander // Cancer Chemotherapy & Pharmacology;Apr2014, Vol. 73 Issue 4, p759 

    Purpose: This population pharmacokinetic model was developed to characterize the pharmacokinetics of the oral irreversible ErbB family blocker afatinib in patients with solid tumors and to investigate the impact of selected intrinsic and extrinsic factors. Methods: Data from 927 patients (4,460...

  • SOLUBILITY ENHANCEMENT OF POORLY WATER SOLUBLE DRUGS. Gohil, Tushar // Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia;2014, Vol. 25 Issue 1, p1 

    Aqueous solubility is a limiting factor in the oral bioavailability of a certain class of poorly water soluble drugs. A consequence of low aqueous solubility is a slow dissolution rate. For the drugs with low aqueous solubility and high permeability the dissolution rate will be the rate limiting...

  • Solid dispersion: A promising technique to enhance solubility of poorly water soluble drug. Sharma1, Anshu; Jain, C.P. // International Journal of Drug Delivery;2011, Vol. 3 Issue 4, p149 

    Poorly water soluble compounds have solubility and dissolution related bioavailability problems. The present review deals in detail about solid dispersion technology and its manufacturing techniques at laboratory and industrial level. This highlight about various hydrophilic polymers used in...

  • Recent Advances on Aqueous Solubility Prediction. Junmei Wang; Tingjun Hou // Combinatorial Chemistry & High Throughput Screening;Jun2011, Vol. 14 Issue 5, p328 

    No abstract available.

  • IMPROVEMENT OF DRUG SOLUBILITY USING SOLID DISPERSION. Kaur, Jatinder; Aggarwal, Geeta; Singh, Gurpreet; Rana, A.C. // International Journal of Pharmacy & Pharmaceutical Sciences;Mar2012, Vol. 4 Issue 2, p47 

    The solubility behaviour of drug is one of the most challenging aspects in formulation development. Thus a greater understanding of dissolution and absorption behaviour of drug with low aqueous solubility is required to successfully formulate them into more soluble and hence bioavailable drug...

Share

Other Topics